Essential roles of 11β-HSD1 in regulating brown adipocyte function

Journal of Molecular Endocrinology

Volumn 50, Issue 1, 2012, Pages 103-113

  Liu, Juan ^a   Kong, Xiaocen ^a   Wang, Long ^a   Qi, Hanmei ^a   Di, Wenjuan ^a   Zhang, Xiao ^c   Wu, Lin ^a   Chen, Xia ^a   Yu, Jing ^a   Zha, Juanmin ^a   Lv, Shan ^a   Zhang, Aisen ^a   Cheng, Peng ^a   Hu, Miao ^a   Li, Yujie ^a   Bi, Jianhua ^a   Li, Yan ^e   Hu, Fang ^e   Zhong, Yi ^d   Xu, Yong ^b   Ding, Guoxian ^a   more..

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NORTHWESTERN UNIVERSITY   (United States)

^d CHINA PHARMACEUTICAL UNIVERSITY   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

11 hydroxysteroid dehydrogenase type 1; Brown adipose tissue; BVT.2733; Fatty oxidation; Obesity

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 3 CHLORO 2 METHYL N [4 [2 (4 METHYL 1 PIPERAZINYL) 2 OXOETHYL] 2 THIAZOLYL]BENZENESULFONAMIDE; ADIPOPHILIN; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PYRUVATE DEHYDROGENASE KINASE 4; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; IN VITRO STUDY; LIPID DIET; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE GROWTH;

EID: 84873335794     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0099     Document Type: Article

References (35)

1. Alberts P, Engblom L, Edling N, Forsgren M, Klingstrom G, Larsson C, Ronquist-Nii Y, Ohman B & Abrahmsen L 2002 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia 45 1528-1532. (doi:10.1007/s00125-002-0959-6)
2. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M et al. 2003 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144 4755-4762. (doi:10.1210/en.2003-0344)
3. Almind K, Manieri M, Sivitz WI, Cinti S & Kahn CR 2007 Ectopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in mice. PNAS 104 2366-2371. (doi:10.1073/pnas. 0610416104)
4. Baudrand R, Carvajal CA, Riquelme A, Morales M, Solis N, Pizarro M, Escalona A, Boza C, Perez G, Dominguez A et al. 2010 Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients. Obesity Surgery 20 77-83. (doi:10.1007/s11695-009-9937-0)
5. Baudrand R, Dominguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N et al. 2011 Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients. Metabolism 60 1775-1780. (doi:10.1016/j.metabol.2011.05.001)
6. Berthiaume M, Laplante M, Festuccia WT, Cianflone K, Turcotte LP, Joanisse DR, Olivecrona G, Thieringer R & Deshaies Y 2007 11β-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues. American Journal of Physiology. Endocrinology and Metabolism 293 E1045-E1052. (doi:10.1152/ajpendo.00276.2007)
7. Bujalska IJ, Kumar S, Hewison M & Stewart PM 1999 Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase. Endocrinology 140 3188-3196. (doi:10.1210/en.140.7.3188)
8. Candia R, Riquelme A, Baudrand R, Carvajal CA, Morales M, Solis N, Pizarro M, Escalona A, Carrasco G, Boza C et al. 2012 Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease. Liver International 32 392-399. (doi:10.1111/j.1478-3231.2011.02685.x)
9. Cannon B & Nedergaard J 2008 Developmental biology: neither fat nor flesh. Nature 454 947-948. (doi:10.1038/454947a)
10. Cypess AM & Kahn CR 2010 Brown fat as a therapy for obesity and diabetes. Current Opinion in Endocrinology, Diabetes, and Obesity 17 143-149. (doi:10.1097/MED.0b013e328337a81f)
11. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A et al. 2009 Identification and importance of brown adipose tissue in adult humans. New England Journal of Medicine 360 1509-1517. (doi:10.1056/NEJMoa0810780)
12. Ellis JM, Li LO, Wu PC, Koves TR, Ilkayeva O, Stevens RD, Watkins SM, Muoio DM & Coleman RA 2010 Adipose acyl-CoA synthetase-1 directs fatty acids toward β-oxidation and is required for cold thermogenesis. Cell Metabolism 12 53-64. (doi:10.1016/j.cmet.2010.05.012)
13. Fasshauer M, Klein J, Kriauciunas KM, Ueki K, Benito M & Kahn CR 2001 Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Molecular and Cellular Biology 21 319-329. (doi:10.1128/ MCB.21.1.319-329.2001)
14. Greenberg AS & Obin MS 2008 Many roads lead to the lipid droplet. Cell Metabolism 7 472-473. (doi:10.1016/j.cmet.2008.05.005)
15. Hondares E, Rosell M, Diaz-Delfin J, Olmos Y, Monsalve M, Iglesias R, Villarroya F & Giralt M 2011 Peroxisome proliferator-activated receptor a (PPARa) induces PPARgamma coactivator 1a (PGC-1a) gene expression and contributes to thermogenic activation of brown fat: involvement of PRDM16. Journal of Biological Chemistry 286 43112-43122. (doi:10.1074/jbc.M111.252775)
16. Kannisto K, Pietilainen KH, Ehrenborg E, Rissanen A, Kaprio J, Hamsten A & Yki-Jarvinen H 2004 Overexpression of 11β-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. Journal of Clinical Endocrinology and Metabolism 89 4414-4421. (doi:10.1210/jc.2004-0153)
17. Kershaw EE, Morton NM, Dhillon H, Ramage L, Seckl JR & Flier JS 2005 Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 54 1023-1031. (doi:10.2337/diabetes.54. 4.1023)
18. Klein J, Fasshauer M, Klein HH, Benito M & Kahn CR 2002 Novel adipocyte lines from brown fat: a model system for the study of differentiation, energy metabolism, and insulin action. Bioessays 24 382-388. (doi:10.1002/bies.10058)
19. Li G, Hernandez-Ono A, Crooke RM, Graham MJ & Ginsberg HN 2012 Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a western-type diet. Metabolism 61 823-835. (doi:10.1016/j.metabol.2011.11.008)
20. Liu Y, Sun Y, Zhu T, Xie Y, Yu J, Sun WL, Ding GX & Hu G 2007 11β-Hydroxysteroid dehydrogenase type 1 promotes differentiation of 3T3-L1 preadipocyte. Acta Pharmacologica Sinica 28 1198-1204. (doi:10.1111/j.1745-7254.2007.00602.x)
21. London E & Castonguay TW 2009 Diet and the role of 11β-hydroxysteroid dehydrogenase-1 on obesity. Journal of Nutritional Biochemistry 20 485-493. (doi:10.1016/j.jnutbio.2009.02.012)
22. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy ND, Schrauwen P & Teule GJ 2009 Cold-activated brown adipose tissue in healthy men. New England Journal of Medicine 360 1500-1508. (doi:10.1056/NEJMoa0808718)
23. Morton NM 2010 Obesity and corticosteroids: 11β-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease. Molecular and Cellular Endocrinology 316 154-164. (doi:10.1016/j.mce.2009.09.024)
24. Orava J, Nuutila P, Lidell ME, Oikonen V, Noponen T, Viljanen T, Scheinin M, Taittonen M, Niemi T, Enerback S et al. 2011 Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metabolism 14 272-279. (doi:10.1016/j.cmet. 2011.06.012)
25. Sawada T, Miyoshi H, Shimada K, Suzuki A, Okamatsu-Ogura Y, Perfield JW II, Kondo T, Nagai S, Shimizu C, Yoshioka N et al. 2010 Perilipin overexpression in white adipose tissue induces a brown fat-like phenotype. PLoS ONE 5 e14006. (doi:10.1371/journal.pone.0014006)
26. Seale P & Lazar MA 2009 Brown fat in humans: turning up the heat on obesity. Diabetes 58 1482-1484. (doi:10.2337/db09-0622)
27. Seckl JR 2004 11β-Hydroxysteroid dehydrogenases: changing glucocorticoid action. Current Opinion in Pharmacology 4 597-602. (doi:10.1016/ j.coph.2004.09.001)
28. Staab CA & Maser E 2010 11β-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. Journal of Steroid Biochemistry and Molecular Biology 119 56-72. (doi:10.1016/j.jsbmb.2009.12.013)
29. Stewart PM & Tomlinson JW 2009 Selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both? Diabetes 58 14-15. (doi:10.2337/ db08-1404)
30. Stimson RH & Walker BR 2007 Glucocorticoids and 11β-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Minerva Endocrinologica 32 141-159.
31. Stryjecki C & Mutch DM 2011 Fatty acid-gene interactions, adipokines and obesity. European Journal of Clinical Nutrition 65 285-297. (doi:10.1038/ ejcn.2010.277)
32. Tateishi K, Okada Y, Kallin EM & Zhang Y 2009 Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458 757-761. (doi:10.1038/nature07777)
33. Tseng YH, Kriauciunas KM, Kokkotou E & Kahn CR 2004 Differential roles of insulin receptor substrates in brown adipocyte differentiation. Molecular and Cellular Biology 24 1918-1929. (doi:10.1128/MCB.24.5. 1918-1929.2004)
34. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerback S et al. 2009 Functional brown adipose tissue in healthy adults. New England Journal of Medicine 360 1518-1525. (doi:10.1056/NEJMoa0808949)
35. Wang L, Liu J, Zhang A, Cheng P, Zhang X, Lv S, Wu L, Yu J, Di W, Zha J et al. 2012 BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice. PLoS ONE 7 e40056. (doi:10.1371/journal.pone.0040056)